By now most healthcare organizations are knee-deep in Meaningful Use (MU) – but a new year means a new stage of MU, which means new requirements, new opportunities for solutions, and new pressures to find the right solution for your organization. That’s where we come in.
Next week Wednesday, February 18, Galen will be presenting a webcast on HL7 interfaces and how they fit into the Meaningful Use puzzle. The focus will be on Meaning Use Stage 2, as only 1% of hospitals and Eligible Professionals completed attestation for that stage in 2014; the bulk of qualified organizations will attest for Stage 2 in 2015 and 2016. The webcast will cover this year’s requirements, thresholds for attestation, new menu objectives, and Clinical Quality Measures.
We will also give a brief overview of HL7 messaging and its role in interoperability. The HL7 standard is used by 95% of U.S. healthcare organizations and boasts backwards capability – meaning HL7 is able to be integrated into nearly any existing information system. We will select seven MU2 objectives (shown below) and take an in-depth look at which HL7 interfaces would be appropriate as solutions.
Next week’s webcast is intended for an audience that have already been exposed to the basics of both Meaningful Use and HL7. However, we have previously presented separate webcasts for beginners on both topics, which can be found on Galen’s Wiki (notably, here are the links for the HL7 Fundamentals webcast and the MU2 Requirements webcast).
You can register for the “Your HL7 Interface and What It Means for Meaningful Use” here. We hope you can join us!